For example, lncRNA FOXD2-AS1 could serve as a novel recurrent marker or a potential target in thyroid cancer [17] and lncRNA ZFAS1 could serve as a novel potential biomarker for predicting the prognosis of thyroid cancer [18]. This evidence concerns the gene FOXD2 and thyroid gland carcinoma.